Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

ClinicalTrials.gov ID: NCT03502616

Public ClinicalTrials.gov record NCT03502616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 8:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY OF THE EFFICACY AND SAFETY OF TOFACITINIB IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS (AS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if tofacitinib is safe and effective in subjects with active ankylosing spondylitis.

Study identification

NCT ID
NCT03502616
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
270 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 7, 2018 (Actual)
Primary completion
Dec 19, 2019 (Actual)
Completion
Aug 20, 2020 (Actual)
Last update posted
Sep 17, 2021

2018 – 2020

United States locations

U.S. sites
28
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Rheumatology Associates of North Alabama, PC Huntsville Alabama 35801 —
Arizona Arthritis & Rheumatology Associates, P.C. Gilbert Arizona 85297 —
Medvin Clinical Research Covina California 91722 —
Rheumatology Center of San Diego PC San Diego California 92128 —
University of California, San Francisco Medical Center San Francisco California 94143 —
Robin K. Dore, MD, Inc. Tustin California 92780 —
New England Research Associates, LLC Bridgeport Connecticut 06606 —
Advanced Radiology Stamford Connecticut 06902 —
Stamford Therapeutics Consortium Stamford Connecticut 06905 —
Southcoast Research Center, Inc. Miami Florida 33136 —
Millennium Research Ormond Beach Florida 32174 —
Bluegrass Community Research, Inc Lexington Kentucky 40504 —
Center for Rheumatology and Bone Research Wheaton Maryland 20902 —
M3-Emerging Medical Research, LLC Durham North Carolina 27704 —
Paramount Medical Research and Consulting, LLC Middleburg Heights Ohio 44130 —
Oregon Health & Science University Portland Oregon 97239 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology Summerville South Carolina 29486 —
Precision Comprehensive Clinical Research Solutions Colleyville Texas 76034 —
Adriana Pop-Moody MD - Clinic PA Corpus Christi Texas 78404 —
Metroplex Clinical Research Center Dallas Texas 75231 —
Clinical Research Unit Houston Texas 77030 —
Investigational Drug Services Houston Texas 77030 —
Memorial Hermann Hospital Imaging Houston Texas 77030 —
Southwest Rheumatology Research LLC Mesquite Texas 75150 —
Trinity Universal Research Associates, Inc. Plano Texas 75024 —
Advanced Rheumatology of Houston The Woodlands Texas 77382 —
Arthritis Northwest, PLLC Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03502616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2021 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03502616 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →